Spirea Alternatives & Competitors
12 companies similar to Spirea — Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique...
Companies similar to Spirea
Araris Biotech AG
Building tomorrow's antibody-drug conjugates (ADCs)
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
ONA Therapeutics
First-in-class ADCs tailored to attack advanced cancer
Antikor Biopharma Ltd
Innovating in and developing the next generation of smaller-format ADCs for cancer therapy...
Rival Readout
Competing with Spirea? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Tagworks Pharmaceuticals
Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapi...
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Sevion Therapeutics
Pioneering groundbreaking therapies for cancer and immunological diseases with innovative...
SciTech Development, Inc.
SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthro...
NBE-Therapeutics AG
Next generation antibody drug conjugates
Photobiotics
Innovative solutions for precise MRI imaging and cancer treatment with advanced drug deliv...
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
About Spirea
Spirea, founded in 2017, is an innovative player in the Biotechnology, Health Care, and Pharmaceutical industries, headquartered in the United Kingdom. Emphasizing its slogan, "Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique Multivalent ELIVATE Linker Technology," Spirea is pioneering a...
Development of next-generation ADCs, ADC linker technology application, Collaborative ADC development
ADC oncology companies, Small molecule oncology companies, Degrader/molecule glue oncology companies, Antibody therapeutics companies, Inflammation and autoimmunity firms
Antibody-Drug Conjugates, Therapeutic Innovation, Drug Delivery Technology, Pharmacokinetics Optimization, Targeted Therapies, Oncology Treatments, Multivalent Linker Technology, Polymer Platform, Clinical Drug Development, Precision Medicine, Therapeutic Payload Expansion, Strategic Partnerships, Pipeline Development
B2B, Platform, API
Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Spirea: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Spirea on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.